Literature DB >> 6167413

Primary liver cell carcinoma complicating autoimmune chronic active hepatitis.

A W Jakobovits, P R Gibson, F J Dudley.   

Abstract

In a group of 50 patients seen with primary liver cell carcinoma over a period of five years, 38 had cirrhosis. In four patients the cirrhosis was due to autoimmune chronic active hepatitis. None of the patients had markers of hepatitis B virus infection, but in three of the four, serum autoantibodies were present. Coexisting autoimmune disease was present in two. Corticosteroids induced remission in all patients, and the liver disease appeared quiescent at the time primary liver cell carcinoma developed.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6167413     DOI: 10.1007/BF01316857

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  14 in total

1.  ACTIVE 'JUVENILE' CIRRHOSIS CONSIDERED AS PART OF A SYSTEMIC DISEASE AND THE EFFECT OF CORTICOSTEROID THERAPY.

Authors:  A E READ; S SHERLOCK; C V HARRISON
Journal:  Gut       Date:  1963-12       Impact factor: 23.059

Review 2.  SJOEGREN'S SYNDROME. A CLINICAL, PATHOLOGICAL, AND SEROLOGICAL STUDY OF SIXTY-TWO CASES.

Authors:  K J BLOCH; W W BUCHANAN; M J WOHL; J J BUNIM
Journal:  Medicine (Baltimore)       Date:  1965-05       Impact factor: 1.889

3.  Relation of carcinoma of the liver to cirrhosis, malaria, syphilis and parasitic diseases.

Authors:  J HIGGINSON
Journal:  Schweiz Z Pathol Bakteriol       Date:  1955

4.  Primary carcinoma of the liver: a study of 100 cases among 48,900 necropsies.

Authors:  H A EDMONDSON; P E STEINER
Journal:  Cancer       Date:  1954-05       Impact factor: 6.860

5.  Hepatocellular carcinoma in Great Britain: influence of age, sex, HBsAg status, and aetiology of underlying cirrhosis.

Authors:  P J Johnson; N Krasner; B Portmann; A L Eddleston; R Williams
Journal:  Gut       Date:  1978-11       Impact factor: 23.059

6.  Familial active chronic hepatitis with hepatocellular carcinoma. Report of a case.

Authors:  R A Joske; B H Laurence; L R Matz
Journal:  Gastroenterology       Date:  1972-03       Impact factor: 22.682

7.  Cirrhosis and hepatoma in alcoholics.

Authors:  F I Lee
Journal:  Gut       Date:  1966-02       Impact factor: 23.059

8.  Natural history of active chronic hepatitis. I. Clinical features, course, diagnostic criteria, morbidity, mortality and survival.

Authors:  S P Mistilis; A P Skyring; C R Blackburn
Journal:  Australas Ann Med       Date:  1968-08

Review 9.  Dermatomyositis and malignancy. A review of the literature.

Authors:  B E Barnes; B Mawr
Journal:  Ann Intern Med       Date:  1976-01       Impact factor: 25.391

10.  Hepatocellular carcinoma in primary biliary cirrhosis: report of four cases.

Authors:  N Krasner; P J Johnson; B Portmann; G Watkinson; R N Macsween; R Williams
Journal:  Gut       Date:  1979-03       Impact factor: 23.059

View more
  7 in total

Review 1.  Hepatocellular carcinoma. A worldwide problem and the major risk factors.

Authors:  R G Simonetti; C Cammà; F Fiorello; F Politi; G D'Amico; L Pagliaro
Journal:  Dig Dis Sci       Date:  1991-07       Impact factor: 3.199

2.  Hepatocellular carcinoma and lupoid hepatitis (an autopsy study).

Authors:  Y H Xu; R L Peters
Journal:  J Tongji Med Univ       Date:  1986

3.  Primary liver cell carcinoma complicating secondary biliary cirrhosis.

Authors:  A Jakobovits; F J Dudley; P Allen
Journal:  Br Med J (Clin Res Ed)       Date:  1984-07-28

4.  Hepatocellular carcinoma in autoimmune hepatitis.

Authors:  S Z Park; D M Nagorney; A J Czaja
Journal:  Dig Dis Sci       Date:  2000-10       Impact factor: 3.199

Review 5.  Hepatocellular carcinoma associated with lupoid hepatitis: a review of Japanese reports.

Authors:  T Sakaguchi; S Nakamura; S Suzuki; R Nishiyama; H Konno; S Baba; H Muro; T Kawasaki
Journal:  Surg Today       Date:  1995       Impact factor: 2.549

Review 6.  Hepatocellular carcinoma and other malignancies in autoimmune hepatitis.

Authors:  Albert J Czaja
Journal:  Dig Dis Sci       Date:  2013-01-10       Impact factor: 3.199

7.  Two patients with extremely elevated tumor markers: where is the malignancy?

Authors:  Patrick P J van der Veek; Wouter H de Vos Tot Nederveen Cappel; Alexandra M J Langers; Bart van Hoek
Journal:  Gastroenterol Res Pract       Date:  2011-06-16       Impact factor: 2.260

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.